Knowledge (XXG)

Template:Growth factor receptors

Source 📝

37: 136: 330: 487: 85: 348: 386: 255: 30: 131: 70: 185: 180: 175: 170: 165: 274: 408: 318: 297: 326: 200: 66: 340: 93: 153: 124: 119: 58: 75: 46: 50: 381: 250: 107: 102: 97: 114: 412: 287: 481: 422: 222: 217: 212: 15: 206: 450:
will show the template collapsed, i.e. hidden apart from its title bar.
415:), it is hidden apart from its title bar; if not, it is fully visible. 358: 353: 407:, meaning that if there is another collapsible item on the page (a 365: 237: 141: 302: 292: 270: 19: 474:
will show the template expanded, i.e. fully visible.
453: 429: 374: 339: 317: 152: 84: 57: 418:To change this template's initial visibility, the 31: 8: 158: 38: 24: 16: 402:initial visibility currently defaults to 86:Receptor protein serine/threonine kinase 419: 7: 413:table with the collapsible attribute 14: 488:Cell surface receptor templates 349:Platelet-derived growth factor 319:Tumor necrosis factor receptor 1: 387:Insulin-like growth factor 2 256:Insulin-like growth factor 1 71:Ciliary neurotrophic factor 504: 132:Bone morphogenetic protein 283: 266: 246: 233: 196: 161: 238:Hepatocyte growth factor 166:Fibroblast growth factor 154:Receptor tyrosine kinase 59:Type I cytokine receptor 458:Growth factor receptors 434:Growth factor receptors 275:Epidermal growth factor 51:growth factor receptors 327:Nerve growth factors 201:Nerve growth factors 67:Nerve growth factors 397: 396: 313: 312: 495: 473: 472: 468: 465: 462: 459: 456: 449: 448: 444: 441: 438: 435: 432: 421: 420:|state= 405: 400:This template's 366:Stem cell factor 331:Low affinity/p75 159: 40: 33: 26: 17: 503: 502: 498: 497: 496: 494: 493: 492: 478: 477: 470: 466: 463: 460: 457: 454: 446: 442: 439: 436: 433: 430: 409:navbox, sidebar 403: 398: 393: 375:Other/ungrouped 370: 335: 309: 279: 262: 242: 229: 192: 148: 80: 53: 44: 12: 11: 5: 501: 499: 491: 490: 480: 479: 476: 475: 451: 395: 394: 392: 391: 390: 389: 378: 376: 372: 371: 369: 368: 363: 362: 361: 356: 345: 343: 341:Ig superfamily 337: 336: 334: 333: 323: 321: 315: 314: 311: 310: 308: 307: 306: 305: 300: 295: 284: 281: 280: 278: 277: 267: 264: 263: 261: 260: 259: 258: 247: 244: 243: 241: 240: 234: 231: 230: 228: 227: 226: 225: 220: 215: 205:high affinity 197: 194: 193: 191: 190: 189: 188: 183: 178: 173: 162: 156: 150: 149: 147: 146: 145: 144: 139: 129: 128: 127: 122: 112: 111: 110: 105: 90: 88: 82: 81: 79: 78: 76:Erythropoietin 73: 63: 61: 55: 54: 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 500: 489: 486: 485: 483: 452: 428: 427: 426: 425:may be used: 424: 416: 414: 410: 406: 388: 385: 384: 383: 380: 379: 377: 373: 367: 364: 360: 357: 355: 352: 351: 350: 347: 346: 344: 342: 338: 332: 328: 325: 324: 322: 320: 316: 304: 301: 299: 296: 294: 291: 290: 289: 286: 285: 282: 276: 272: 269: 268: 265: 257: 254: 253: 252: 249: 248: 245: 239: 236: 235: 232: 224: 221: 219: 216: 214: 211: 210: 209: 208: 202: 199: 198: 195: 187: 184: 182: 179: 177: 174: 172: 169: 168: 167: 164: 163: 160: 157: 155: 151: 143: 140: 138: 135: 134: 133: 130: 126: 123: 121: 118: 117: 116: 113: 109: 106: 104: 101: 100: 99: 95: 92: 91: 89: 87: 83: 77: 74: 72: 68: 65: 64: 62: 60: 56: 52: 48: 41: 36: 34: 29: 27: 22: 21: 18: 417: 404:autocollapse 401: 399: 204: 23: 382:Somatomedin 251:Somatomedin 94:TGF pathway 445:collapsed 423:parameter 47:Receptors 482:Category 469:expanded 98:TGF-beta 115:Activin 464:state 440:state 411:, or 288:VEGF 271:ErbB 223:TrkC 218:TrkB 213:TrkA 207:Trk 484:: 471:}} 455:{{ 447:}} 431:{{ 329:: 203:: 96:: 69:: 49:: 467:= 461:| 443:= 437:| 359:B 354:A 303:3 298:2 293:1 273:/ 186:4 181:3 176:2 171:1 142:2 137:1 125:2 120:1 108:2 103:1 39:e 32:t 25:v

Index

v
t
e
Receptors
growth factor receptors
Type I cytokine receptor
Nerve growth factors
Ciliary neurotrophic factor
Erythropoietin
Receptor protein serine/threonine kinase
TGF pathway
TGF-beta
1
2
Activin
1
2
Bone morphogenetic protein
1
2
Receptor tyrosine kinase
Fibroblast growth factor
1
2
3
4
Nerve growth factors
Trk
TrkA
TrkB

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.